Robustness of GLP1R-Region Mendelian Randomization Estimates for Heart Failure
Genes · 08.11.2026 · 17 (11) · 1410
DOI: 10.3390/genes17111410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 08.11.2026. Verfasst von Wantong Wang und 3 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Physician Scientist Training Project, Young Elite Scientists Sponsorship Program of the Beijing High Innovation Plan.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background/Objectives: We assessed the robustness of GLP1R-region Mendelian randomization estimates for heart failure (HF) across instruments, outcome sources and uncertainty models.
Methods
HbA1c associations from GCST90014006 were combined with Henry, HERMES and European-ancestry GBMI HF data. Eleven-, seven- and four-variant instruments were evaluated using correlated-variant generalized least squares (GLS), alternative linkage disequilibrium (LD), influence analysis, type 2 diabetes calibration and exposure-error sensitivity analyses. Effects represented a one-unit decrease in inverse-rank-normal-transformed HbA1c.
Results
The principal Henry 11-variant multiplicative random-effects estimate was an approximate relative risk of 0.568 (95% confidence interval 0.299–1.080), with Q = 29.998 on 10 degrees of freedom. The fixed-effect interval was 0.392–0.823; a t-reference interval was 0.274–1.179. Exposure-error profile likelihood gave 0.511 (0.233–1.008), with residual heterogeneity supported by simulation. The four-variant GLS estimate was 0.909 (0.574–1.439). Eleven-variant odds ratios were 0.369 (0.206–0.659) in HERMES and 0.528 (0.317–0.880) in GBMI. Nine available variants gave a type 2 diabetes odds ratio of 0.204 (0.112–0.370).
Conclusions
Protective point estimates varied with outcome source and instrument composition. Heterogeneity-aware uncertainty remained substantial after exposure-error sensitivity analysis. Glycaemic calibration and regional evidence require interpretation alongside variant-specific function when assessing pharmacological GLP-1R agonism.
Förderung
- National Natural Science Foundation of China
- Beijing Physician Scientist Training Project
- Young Elite Scientists Sponsorship Program of the Beijing High Innovation Plan
- National High Level Chinese Medicine Hospital
Zitieren
APA
Wang, W., Zhao, Y., Wang, J., & Wang, C. (2026). Robustness of GLP1R-Region Mendelian Randomization Estimates for Heart Failure. Genes, 17(11), 1410. https://doi.org/10.3390/genes17111410
Vancouver
Wang W, Zhao Y, Wang J, Wang C. Robustness of GLP1R-Region Mendelian Randomization Estimates for Heart Failure. Genes. 2026;17(11):1410. doi:10.3390/genes17111410
BibTeX
@article{Wang2026,
author = {Wang, Wantong and Zhao, Yafu and Wang, Junqing and Wang, Chao},
title = {Robustness of GLP1R-Region Mendelian Randomization Estimates for Heart Failure},
journal = {Genes},
year = {2026},
volume = {17},
number = {11},
pages = {1410},
doi = {10.3390/genes17111410}
}
EUVIMED